RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 2:42 AM
Followers: 439
Posts Today: 1
Views Today: 66319

CYDY Stock Quote & Tools

$0.2054 ▲ +0.0054 (+2.69%) As of Oct 15, 3:59 PM EDT
Last0.2054
$ Chg0.0054
Open0.2000
High0.2090
Beta1.4964
Year High0.397
Market Cap301.80M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume3.28M
% Chg+2.69%
Prev Close0.2000
Low0.1971
VWAP0.20198
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. CDiddy

    Yep. T Trades.

  2. Bw

    Idk but they went through on time and sales at 15:06 ... Was a hidden seller again today keeping

  3. Trimble

    trades were for 200K, 200K, and 12522 shares..

  4. Trimble

    412,522 shares traded after the bell at $5.0013...3 trades printed...T-trades

  5. kabonk

    One could try to reverse engineer their power calculations and assumptions on the study, using a

  6. Evil Rabbit

    Anyone else think wed be at $8 if Mgmt had not had a CC and, instead, allowed the mystery to

    (5)
  7. MD VIROLOGIST

    Half of cardiac transplants are for viral myocarditis.

  8. MD VIROLOGIST

    all viruses can cause that.

  9. mtruong34

    @Doctor580. Just to be clear, no one uses the currently approved mabs because they are not allowed

    (1)
  10. MD VIROLOGIST

    For example if patients with the highest RO had 100% survival it would be very compelling. What I

    (1)
  11. smlf

    Do you mind sharing the info you shared with Cdiddy via a private message? Thank you in advance.

  12. CTMedic

    smurph, I believe it much more likely that cardiac inflammation is a result of the systemic

  13. ohm20

    Is there a cardiologist in the room? I'm not one. Does COVID cause cardi

  14. Doctor580

    Let me make this clear from a clinical view point. I currently have 29 intubated covid pts and an

    (25)
  15. smurph

    CT, "but of course here we are back with inflammation." Does COVID cause cardio-inflammation?

  16. CTMedic

    MD Virologist (and Havasu) I agree that RO is a powerful tool. However, it is the effect of

    (3)
  17. CDiddy

    Great point. I hadn't even considered that.

  18. CDiddy

    You could be right, but I suspect that a meaningful mortality reduction is all we

    (1)
  19. ohm20

    Your friend should know what receptor occupancy was from EINDs.

    (3)
  20. ohm20

    We already know that 700mg is optimal or near optimal receptor occupancy in a high viral

    (5)
  21. MD VIROLOGIST

    I am not bashing, RO is a powerful tool, if the efficacy is established and all had high receptor

  22. CDiddy

    I would add (from my non-medically trained mind), that RO is vital in HIV in order to bring the

    (4)
  23. Doctor580

    I have warned you about MD virologist in the past Cdiddy. But your right, this is inevitable. My

    (14)
  24. MD VIROLOGIST

    Thank you for your patience.

  25. MD VIROLOGIST

    Sorry, not trying to be offensive, I am simply concerned about that specific point, I will keep my

    (2)
  26. CTMedic

    Chuckles, It certainly seems that additional trials to fine tune Leronlimab use would be

    (2)
  27. CDiddy

    I'm trying to be patient MD, but the phrases and inferences that you select are shining a light on

    (21)
  28. chuckles759

    CTMedic, Would the RO assays be best done during a Phase 4 to tweak dosing, administration for

    (1)
  29. MD VIROLOGIST

    If the lack of that data point is not there it is not an endpoint but maybe considered of the

    (1)
  30. Riztheinvestor

    Just wanted to say hope everyone is well and have a great trading week ! Very busy week for me at

    (3)
  31. CTMedic

    Havasu, I appreciate your enthusiasm for leronlimab RO data, but I believe it is misplaced.

    (16)
  32. Shelly2626

    Exactly...we have seen it a few times before....they always use whatever they can to get the

    (2)
  33. havasu78

    Thanks ohm. I can see now that the power is based on whether the mathematical difference between

  34. CDiddy

    RO is not important. The only thing that matters is the primary endpoint. Those that make

    (13)
  35. JLang

    The FDA won't be nearly as interested in RO as in clinical outcomes... NEWS2 is way more useful. RO

    (4)
  36. Drano

    Article: "Vaccines aren't enough. We need more COVID-19 treatments too."

  37. sean007

    De Minimus..." Too trivial to support any effect"......shorts are going to get reamed..no matter

    (1)
  38. havasu78

    If there is no CCR5 RO test being performed in CD12, then that is potentially the most massive

    (2)
  39. MarcS

    They should have radio silence until they have top line results. No PR that the last patient

    (29)
  40. JLang

    I think the long strategy should be to trumpet the results we're expecting in -Mid to Late Feb-.

    (4)
  41. sean007

    Not. sure I posted anything that hasn't been deleted as of late.....remind me of the

  42. ohm20

    Rates of mortality reported in hospitalized patients vary widely but have consistently been

    (4)
  43. mtruong34

    100% agreement here. If you can recall, AF wrote a hit piece on STAT when cd10 was pending analysis

    (6)
  44. CDiddy

    Make no mistake, this is (I believe) the shorts strategy. Hype everyone up that results are

    (11)
  45. WUM

    The Mayo Cinic data show, the calculation works, when there are 17 deaths among outpatients, 42

  46. jamming1092

    That would be great to hear those numbers - especially the recoveries (as well as insight into turn

  47. onestepahead

    Im feeling kinda lazy but part of me wants to include links to six other large studies that show

  48. sean007

    Looked in on Stocktwits.... a much younger crowd...given emojis, etc....very committed to the

  49. Shelly2626

    Oh....we are having fun ....watching the bashers squirm is always fun !!! Go CYDY !!!!

    (1)
  50. WUM

    There is something wrong with the calculation, of course... But Pricepershare also sees that, he

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

HTX Launches Anniversary Campaign with $80,000 in Rewards

Updated Category News Views 122

HTX Celebrates 12 Years with Exciting Trading Competitions PANAMA CITY — To honor its 12th anniversary, HTX, a prominent player in the cryptocurrency exchange landscape, is excited to unveil two major trading campaigns. The campaigns are titled the Margin Loan & Trading Dual Challenge and the Hot Crypto Futures Trading Challenge. Together, they provide a total prize...

Continue Reading
Insights on Rathbones Group Plc and Balanced Property Trust

Updated Category News Views 108

Understanding Recent Disclosures by Rathbones Group Plc In the world of finance and investments, transparency is crucial. Recently, Rathbones Group Plc made public disclosures under the regulations governing market transactions, particularly concerning its interests in Balanced Commercial Property Trust Limited. This disclosure is significant as it not only reflects...

Continue Reading
TheSushiDragon Partners with StreamerDap to Empower Creators

Updated Category News Views 285

TheSushiDragon Joins StreamerDap as Co-Owner In a groundbreaking move for the live streaming community, TheSushiDragon, a prominent Twitch creator, has officially entered an equity partnership with StreamerDap, a leading platform revolutionizing the sponsorship landscape for creators. This innovative partnership aims to enhance the creator experience, making sponsorships...

Continue Reading
Understanding the Recent Trends in CACI International's Short Interest

Updated Category News Views 53

Exploring CACI International's Short Interest Trend CACI International (NYSE: CACI) has recently seen a notable rise in its short percent of float, now standing at 10.26% since the last report. Currently, there are 169 thousand shares sold short, equating to 0.86% of all regular shares available for trading. Significance of Short Interest Understanding short interest is...

Continue Reading
Instem Unveils Innovative Cloud Solution for Pathology Management

Updated Category News Views 115

Innovative Pathology Module for Efficient Research Instem has recently introduced its groundbreaking Non-GLP Pathology Module, a significant enhancement for its renowned Provantis platform. This innovative module is designed to improve the quality and efficiency of in vivo preclinical study management. By leveraging cutting-edge cloud technology, it simplifies the...

Continue Reading